Iran Memorial

Quitting Ozempic Is a Risky Proposition - Newser

Google News1/31/2026

Summary

Quitting Ozempic poses risks, as highlighted by various sources. The Wall Street Journal discusses the consequences of stopping Ozempic and Wegovy, while the New York Post reports on the emergence of 'agonorexia,' linked to GLP-1 medications, which may lead to new eating disorders. Additionally, HOLA provides expert advice on avoiding Ozempic’s “rebound effect.” Concerns about the long-term effectiveness of popular weight loss drugs like Ozempic are raised by ScienceDaily.

Share:XRedditLinkedIn

Advertisement

Lindy Score Breakdown (V4.2)

30d
Age
1
Sources
from cluster
723
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^723/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^723/48 = 0.000029) reduced it below 0.5

Score BreakdownRisk 50

Source Reputation: Low-trust source (6/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 30 days - proven survivor

Stories gain Lindy status through source reputation, network consensus, and time survival.

Breaking Similar stories